The Hang Seng Index is approaching its highest level in nearly 3 years, with Chinese brokerage, insurance, and stablecoin concept stocks remaining hot!
July 11 news, Hong Kong stocks' three major indices rose together. In terms of sectors, technology stocks rose together, and most securities and brokerage stocks went up.
In addition, on July 10, the Shanghai State-owned Assets Supervision and Administration Commission held a stablecoin study meeting, and stablecoin concept stocks rose. Institutions are optimistic about the strong development of the industry chain. Previously, Hong Kong's "Stablecoin Ordinance" is planned to be officially implemented on August 1, 2025, and the United States and Europe are actively promoting stablecoin legislation.
Stimulated by this news, stablecoin concept stocks soared across the board! Hong Kong stocks have had many hot spots this year, with insurance, biotechnology, and new consumption sectors always being popular.
The chart below shows the year-to-date increase statistics as of June 27, 2025.
Traditional brokers are entering the crypto assets market, enhancing crypto market liquidity!
With licensed brokers entering the market, high-net-worth clients and institutional investors are gaining access to safe and reliable crypto asset investment channels for the first time. This will not only attract a large influx of new funds but also significantly enhance the liquidity and stability of the crypto market.
$ZA ONLINE(06060.HK) : The first licensed bank in Hong Kong to provide stablecoin reserve banking services
$LIANLIAN(02598.HK) : Collaborating with Circle Technology on stablecoin application projects in cross-border payment scenarios
$OSL GROUP(00863.HK) : Hong Kong compliant exchange, Hong Kong version "Coinbase"
$CHINA EB LTD(00165.HK) : One of Circle's investors
$LINKLOGIS-W(09959.HK) : Deep cooperation with Standard Chartered on stablecoin projects
Stablecoins reshape broker valuation logic, opening up growth space for brokers!
Stablecoins are expected to drive a fundamental transformation in the role of brokers. In the future, brokers will no longer be just simple "stock trading intermediaries" but will turn into asset securitization engines and cross-border clearing hubs. This role transformation will become a key catalyst for valuation enhancement!
$CITIC SEC(06030.HK) : Leading brokers accelerate the layout of related businesses
$CGS(06881.HK) : Retail brokerage transforms into a digital asset gateway
$CICC(03908.HK) : Global stablecoin regulatory think tank + leading institution service provider
$EB SECURITIES(06178.HK) : Circle shareholder, benefiting from stablecoin listing dividends
$GUOTAI JUNAN I(01788.HK) : The first Chinese-funded broker to obtain a virtual asset trading license
Young people's Moutai, the new consumption sector is attracting attention.
Pop Mart, Lao Pu Gold, Mi Xue Group, and other new consumption stocks are among the hottest topics in the market this year. Against the backdrop of slowing traditional consumption growth, policy changes, and generational shifts in consumption, funds are turning to the new consumption track. The core logic lies in the resonance of "emotional value + brand innovation + high growth potential."
New consumption upgrades products from functional carriers to emotional anchors and social symbols through strategies such as IP co-branding, limited releases, and storytelling design, precisely targeting the "self-pleasing consumption" and circle identity needs of Generation Z, making consumers willing to pay for "brand superiority."
$POP MART(09992.HK) : IP trendy toy leader, blind box economy pioneer, anchoring Generation Z's social needs
$LAOPU GOLD(06181.HK) : New noble in ancient gold, "national trend + luxury" positioning to leverage the new generation wedding market
$MAO GEPING(01318.HK) : Representative of domestic beauty brands, "Oriental aesthetics + master IP" creates high-end premium
$CHICMAX(02145.HK) : New skincare technology, achieving big brand alternatives through biological fermentation technology
$MIXUE GROUP(02097.HK) : King of tea drinks in lower-tier markets, extreme cost-effectiveness + scale effect of thousands of stores
$XIAOMI-W(01810.HK) : Technology consumption benchmark, founder IP and ecosystem model binding young families
$BLOKS(00325.HK) : Dark horse in the building block world, opening up China's educational toy market
$GUMING(01364.HK) : Pioneer of tea drinks going overseas, "Chinese milk tea + localized flavors" opening up the market
The biopharmaceutical sector is strongly rebounding, valuation recovery is underway.
The current biopharmaceutical industry is experiencing a dual drive of "innovation realization + globalization breakthrough."
In terms of policy, medical insurance negotiations accelerate the volume of innovative drugs. According to incomplete statistics, from the beginning of 2025 to the end of May, a total of 53 new drugs have been approved for listing in China (excluding innovative Chinese medicine), promoting domestic substitution.
Chinese pharmaceutical companies are gradually opening up overseas markets. Although the problem of target homogeneity still exists, differentiated fields such as gout, metabolism, and rare diseases are becoming new blue oceans. In the future, the industry needs to find a balance between short-term profitability and long-term technology reserves, but under the main line of innovation, the valuation recovery space for leading companies is clear.
The following companies are worth paying attention to: $BEONE MEDICINES(06160.HK) , $AKESO(09926.HK) , $WUXI APPTEC(02359.HK) , $REMEGEN(09995.HK) , $WUXI BIO(02269.HK) , $HENGRUI PHARMA(01276.HK)
Insurance funds accelerate their entry, guiding long-term funds into the market!
Under the dual pressure of low interest rates and "asset shortage," insurance funds are accelerating their allocation to Hong Kong stocks—high dividend assets have become an important direction for their strategic layout. The Hong Kong market, with its high dividend characteristics, valuation advantages, and close linkage with the mainland economy, is attracting insurance funds to continue increasing their positions.
The following companies are worth paying attention to: $PING AN(02318.HK) , $PICC P&C(02328.HK) , $AIA(01299.HK) , $NCI(01336.HK) , $CHINA LIFE(02628.HK) , $CPIC(02601.HK)
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
